VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

EBMT 2020 | Challenges associated with CAR T-cell production

Valentín Ortiz-Maldonado • 1 Sep 2020
EBMT 2020
Diffuse Large B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma
Treatment

Valentín Ortiz-Maldonado, MD, Hospital Clinic, Barcelona, Spain, discusses challenges associated with CAR T-cell production. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Valentín Ortiz-Maldonado

3:35
Sinusoidal obstruction syndrome in patients with R/R B-cell ALL
Valentín Ortiz-Maldonado • 1 Sep 2020
1:12
ARI-0001 in CD19+ malignancies: next steps
Valentín Ortiz-Maldonado • 3 Feb 2021
3:11
ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease
Valentín Ortiz-Maldonado • 3 Feb 2021
8:17
CART19-BE-01: ARI-0001 in CD19+ malignancies
Valentín Ortiz-Maldonado • 11 Oct 2020

Related Videos

3:02
Phase I study of rapcabtagene autoleucel in patients with R/R DLBCL
Nirav Shah • 15 Feb 2023
3:19
Safety and efficacy of LV20.19 CAR-T therapy in Richter's transformation and R/R MCL
Nirav Shah • 15 Feb 2023
2:17
The importance of managing hematologic toxicity associated with CAR-T therapy
Marion Subklewe • 10 Feb 2023
1:23
CARBON trial: investigating CTX110 allogeneic CRISPR-Cas9–engineered CAR-Ts in R/R LBCL
Constantine Tam • 12 Dec 2022
The content of VJRegenMed is intended for healthcare professionals